BofA Securities analyst Tazeen Ahmad initiates coverage on Definium Therapeutics Inc (NASDAQ: DFTX) with a Buy rating and a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments Hot New Coverage New Coverage